International study of MultiStem cell therapy for ischemic stroke

Trial Profile

International study of MultiStem cell therapy for ischemic stroke

Planning
Phase of Trial: Phase III

Latest Information Update: 13 Mar 2018

At a glance

  • Drugs Allogeneic stem cell therapy Athersys (Primary)
  • Indications Stroke
  • Focus Registrational; Therapeutic Use
  • Acronyms MASTERS-2
  • Sponsors Athersys
  • Most Recent Events

    • 13 Mar 2018 According to an Athersys media release, the company is planning to launch this trial in the second quarter 2018.
    • 08 Aug 2017 According to an Athersys media release, design of this trial has received a Final Scientific Advice positive opinion from the European Medicines Agency. Also US FDA has granted Fast Track Designation for Multistem.
    • 28 Sep 2016 According to an Athersys media release, this trial is expected to initiate in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top